Patient Advocate Foundation Announces Additional Support for Co-Pay Relief Program Serving Multiple Myeloma Patients

Patient Advocate Foundation Announces Additional Support for Co-Pay Relief
Program Serving Multiple Myeloma Patients

Co-Pay Relief Program Provides Direct Financial Support for Pharmaceutical
Co-Payments to Insured Patients in Medical and Financial Need

WASHINGTON, Nov. 12 /PRNewswire-USNewswire/ -- Patient Advocate Foundation
(PAF) -- a national non-profit organization that seeks to safeguard patients
through effective mediation assuring access to care, maintenance of employment
and preservation of their financial stability relative to their diagnosis of
life threatening or debilitating diseases -- is pleased to announce that it
has received additional funding support for serving patients with multiple
myeloma through its Co-Pay Relief Program (CPR).

PAF's Co-Pay Relief Program provides direct financial support for
pharmaceutical co-payments to insured patients, including Medicare Part D
beneficiaries, who financially and medically qualify. Since the program's
inception in April 2004, CPR distributed more than $50 million in assistance
to over 25,000 patients who were unable to afford their pharmaceutical
co-payments.

"Patient Advocate Foundation is committed to improving the quality of life of
patients facing medical and financial hardship through our professional case
management and Co-Pay Relief services. We are thrilled to announce additional
funding for our Co-Pay Relief Program, which will allow us to offer financial
assistance to a larger number of Multiple Myeloma patients across the nation,"
said Nancy Davenport-Ennis, Founder and CEO of PAF. "A cancer diagnosis can
be the most overwhelming experience a person may ever face in his or her
lifetime. Coupled with high-cost pharmaceutical co-pay expenses, the journey
can become significantly more challenging to manage -- so we are particularly
pleased to be able to offer assistance to more patients."

"We are so pleased that the Patient Advocate Foundation was able to secure
this additional funding for Multiple Myeloma patients. Through PAF's Co-Pay
Relief Program, this funding will help Multiple Myeloma patients to better
utilize their healthcare coverage, which will lead to more thorough management
of their disease," said Anne Quinn Young, MPH, Director of Programs, Multiple
Myeloma Research Foundation.

Multiple myeloma is a cancer of the plasma cell, an important part of the
immune system that produces antibodies to help fight infection and disease.

Patient Advocate Foundation and its companion organization, the National
Patient Advocate Foundation (NPAF), were founded on the principle that health
care is a basic human need and shared social responsibility. Annually, PAF
receives thousands of contacts requesting information and assistance via their
toll-free hotline as well as online, with complete direct, sustained case
management services provided to patients from all fifty states free of charge.
For more information about PAF, visit www.patientadvocate.org or call toll
free (800) 532-5274. For more information about PAF's Co-Pay Relief Program
visit www.copays.org or call toll free (866) 512-3861.

SOURCE Patient Advocate Foundation

Leigh Ann Bradley, +1-703-548-0019, for Patient Advocate Foundation